Subtipos histopatológicos do linfoma de Hodgkin (classificação da OMS)

Subtipos histopatológicos do linfoma de Hodgkin (classificação da OMS)

Tipo histológico

Aparência morfológica

Imunofenótipo da célula neoplásica

Clássico

Esclerose nodular

Tecido fibroso denso ao redor de nódulos de tecido de Hodgkin

CD15+, CD30+, CD20—

Celularidade mista

Número moderado de células de Reed-Sternberg com infiltrado basal misto

CD15+, CD30+, CD20—

Rico em linfócitos

Poucas células de Reed-Sternberg

Muitas células B

CD15+, CD30+, CD20—

Esgotamento de linfócitos

Numerosas células de Reed-Sternberg

Fibrose extensa

CD15+, CD30+, CD20—

Predominantemente linfocitário nodular*

Poucas células neoplásicas (células linfocíticas e histiocíticas)

Muitas células B pequenas

Padrão nodular

CD15— CD30— CD20+, EMA+

AME = antígeno da membrana epitelial.

* Nodular lymphocyte-predominant Hodgkin lymphoma has been reclassified as an non-Hodgkin B-cell lymphoma by the International Consensus Classification and is called nodular lymphocyte predominant B-cell lymphoma (see Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [published correction appears in Blood 2023 Jan 26;141(4):437]. Blood 2022;140(11):1229-1253. doi:10.1182/blood.2022015851). 

AME = antígeno da membrana epitelial.

* Nodular lymphocyte-predominant Hodgkin lymphoma has been reclassified as an non-Hodgkin B-cell lymphoma by the International Consensus Classification and is called nodular lymphocyte predominant B-cell lymphoma (see Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [published correction appears in Blood 2023 Jan 26;141(4):437]. Blood 2022;140(11):1229-1253. doi:10.1182/blood.2022015851). 

Nesses tópicos